Trials / Conditions / Relapsed or Refractory Lymphoma
Relapsed or Refractory Lymphoma
5 registered clinical trials studyying Relapsed or Refractory Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma NCT07453446 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Phase 1 |
| Recruiting | Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or NCT06918912 | Istituto Clinico Humanitas | Phase 2 |
| Completed | HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study NCT05720767 | Hutchmed | Phase 1 |
| Completed | HMPL-523 Food Effect and Proton Pump Inhibitor Study NCT05571787 | Hutchmed | Phase 1 |
| Completed | HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI NCT05602597 | Hutchmed | Phase 1 |